The Clinical Trial Company was formed in the UK in 2002 by Ewan Campbell and Kerri Leeming, both previously senior level personnel within the clinical research sector. They realised there was an opportunity in the CRO sector for a company which targeted medium size clinical trials and novel products which lacked a classical road map to the market. Large CROs prioritise studies from the big pharma companies, for good business reasons. However, this approach sometimes disadvantages their smaller clients who are equally keen to complete their clinical trials quickly.
Thus, The Clinical Trial Company corporate structure facilitates commercial efficiency and cost effectiveness in helping bring clients’ products to market. Where possible, traditional “one size fits all” lengthy approval routes are replaced with pragmatic real-life planning without risk to long term success.
Its Directors and experienced management team offer comprehensive client-side experience to global players.This offering appeals to people unhappy with delays caused by conventional off-the-shelf approval strategies which ignore the unique nature of each product and market.
The company enjoys an open and enthusiastic culture which results in maximum personal motivation. Staff are flexible and embrace new challenges. Continuous cross-fertilisation across disciplines is encouraged, resulting in high levels of personal job satisfaction.
The Company delivers planning, navigation and execution of innovative clinical programmes worldwide.
